Skip to main content
SpringerLink
Log in

Role of Renin in the Control of the Circulation in Hypertensive Disease and in Heart Failure

  • Chapter
Hypertensive Cardiovascular Disease: Pathophysiology and Treatment

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 16))

  • 232 Accesses

Abstract

That renin plays an integral role in blood pressure homeostasis and in the pathogenesis of hypertension has been appreciated since its discovery by Tigerstedt and Beman at the turn of the century. The specific role of renin in the production of various forms of hypertension remains a subject of lively debate [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hypertension - the chicken and the egg (editorial). Lancet 1: 345, 1976.

    Google Scholar 

  2. Oparil S, Haber E: The renin-angiotensin system (pts 1 and 2). N Engl J Med 291: 389, 446, 1974.

    Article  PubMed  CAS  Google Scholar 

  3. Haber E: The renin-angiotensin system and hypertension.Kidney Int. 15: 427, 1979.

    Article  PubMed  CAS  Google Scholar 

  4. Slater EE, Cohn RC, Dzau VJ et al.: Purification of human renal renin. Clin Sci Mol Med 55: 117S, 1978.

    CAS  Google Scholar 

  5. Haber E, Koerner T, Page LB et al.: Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349, 1969.

    Article  PubMed  CAS  Google Scholar 

  6. Wallach L, Nyarai I, Dawson KG: Stimulated renin: a screening test for hypertension. Ann Intern Med 82: 27, 1975.

    PubMed  CAS  Google Scholar 

  7. Kaplan NM, Kem DC, Holland DB et al.: The intravenous furosemide test: a simple way to evaluate renin responsiveness. Ann Intern Med 84: 639, 1976.

    PubMed  CAS  Google Scholar 

  8. Swales JD: The hunt for renal hypertension. Lancet 1: 577, 1976.

    Article  PubMed  CAS  Google Scholar 

  9. Poulsen k, Sancho J, Haber E: A simplified radioimmunoassay for plasma aldosterone employing an antibody of unique specificity. Clin Immunol Immunopathol 2: 273, 1974.

    Article  Google Scholar 

  10. Sancho J, Re RN, Kliman B, Haber E: Diurnal variation of plasma aldosterone in low renin hypertension. Circulation 50 (Suppl 3): 202, 1974.

    Google Scholar 

  11. Vagnucci AH, McDonald RH Jr, Drash AL, Wong AKC: Intradian changes of plasma aldosterone, Cortisol, corticosterone, and growth hormone in sodium restriction. J Clin Endocr 38: 761, 1974.

    Article  PubMed  CAS  Google Scholar 

  12. Deodhar SD, Haas E, Goldblatt H: Production of antirenin to homologous renin and its effect on experimental renal hypertension. J Exp Med 119: 425, 1964.

    Article  PubMed  CAS  Google Scholar 

  13. Romero JC, Hoobler SW, Kozak TJ, Warzynski RJ: Effect of antirenin in blood pressure of rabbits with experimental renal hypertension. Am J Physiol 225: 810, 1973.

    PubMed  CAS  Google Scholar 

  14. Wakerlin GE: Antibodies to renin as proof of the pathogenesis of sustained renal hypertension. Circulation 16: 653, 1958.

    Google Scholar 

  15. Dzau VJ, Kopelman RI, Barger AC et al.: Renin specific antibody for study of cardiovascular homeostasis. Science 207: 1091, 1980.

    Article  PubMed  CAS  Google Scholar 

  16. Gross F, Lazar J, Orth H: Inhibition of the renin-angiotensinogen reaction by pepstatin. Science 175: 656, 1972.

    Article  PubMed  CAS  Google Scholar 

  17. Kokubu T, Hiwada K, Nagasaka Y, Yamamura Y: Effect of several proteinase inhibitors on renin reaction. Jpn Circulat J (En) 38: 955, 1974.

    Article  CAS  Google Scholar 

  18. Menard J, Gardes J, Kreft C, Evin G, Castro B, Corvol P: Soluble pepstatin: a new approach in the in vivo blockade of the renin-angiotensin system. In. Proceedings of the 5th Meeting of the International Society of Hypertension, 1978. Clin Sci Mol Med 55 (Suppl 4): 167s, 1978.

    Google Scholar 

  19. Burton J, Poulsen K, Haber E: Competitive inhibitors of renin: Inhibitors effective at physiological pH. Biochemistry 14: 3892, 1975.

    Article  PubMed  CAS  Google Scholar 

  20. Poulsen K, Burton J, Haber E: Competitive inhibitors of renin. Biochemistry 12: 3877, 1973.

    Article  PubMed  CAS  Google Scholar 

  21. Skeggs LT Jr, Kahn JR, Lentz KE, Shumway NP: The preparation, purification and amino acid sequence of a polypeptide renin substrate. J Exp Med 106: 439, 1957.

    Article  PubMed  CAS  Google Scholar 

  22. Skeggs LT, Lentz KE, Kahn JR, Hochstrasser H: Kinetics of the reaction of renin with nine synthetic peptide substrates. J Exp Med 128: 13, 1968.

    Article  PubMed  CAS  Google Scholar 

  23. Haber E, Burton J: Inhibitors of renin and their utility in physiologic studies. Fed Proc 38: 2768, 1979.

    PubMed  CAS  Google Scholar 

  24. Cody RJ Jr, Burton J, Herd JA, Haber E: Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin dependent hypertension. Proc Natl Acad Sci USA 77: 5476, 1980.

    Article  PubMed  Google Scholar 

  25. Ferreira SH: A bradykinin-potentiating factor (BPF) present in the venom of Bothrops Jararca. Br J Pharmacol 24: 163, 1965.

    CAS  Google Scholar 

  26. Bakhle YS: Inhibition of angiotensin I converting enzyme by venom peptides. Br J Pharmacol 43: 252, 1971.

    PubMed  CAS  Google Scholar 

  27. Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, Kocy O: Angiotensin converting enzyme inhibitors from the venom of Bothrops jararca: isolating elucidation of structure and synthesis. Biochemistry 10: 4033, 1971.

    Article  PubMed  CAS  Google Scholar 

  28. Ondetti MA, Rubin B, Cushman DW: Design of specific inhibitors of angiotensin converting enzyme: new class of orally active antihypertensive agents. Science 196: 441, 1977.

    Article  PubMed  CAS  Google Scholar 

  29. Pals DT, Masucci FD, Sipos F, Denning GS Jr: A specific competitive antagonist of the vascular action of angiotensin II. Circ Res 29: 664, 1971.

    PubMed  CAS  Google Scholar 

  30. Khosla MC, Smeby RR, Bumpus FM: Structure-activity relationships in angiotensin II analogs. In: Angiotensin, p. 126. Page H, Bumpus FM, eds. Berlin: Springer Verlag, 1974.

    Google Scholar 

  31. Johnson JA, Davis JO, Spielman WS, Freeman RH: The role of the renin-angiotensin system in experimental renal hypertension in dogs. Proc Soc Exp Biol 147: 387, 1974.

    PubMed  CAS  Google Scholar 

  32. Streeten GHP, Anderson GH, Freiberg JM, Dalakos TG: Use of an angiotensin II antagonist (saralysin) in the recognition of ‘angiotensinogenic’ hypertension. N Engl J Med 292: 657, 1975.

    Article  PubMed  CAS  Google Scholar 

  33. Bianchi A, Evans DB, Cobb M, Peschka MT, Schaeffer TR, Laffan RJ: Inhibition by SQ20881 of vasopressor response to angiotensin I in conscious animals. Eur J Pharmacol 23: 90, 1973.

    Article  PubMed  CAS  Google Scholar 

  34. Miller ED Jr, Samuels AI, Haber E, Barger AC: Inhibition of angiotensin conversion in experimental renovascular hypertension. Science 177: 1108, 1972.

    Article  PubMed  CAS  Google Scholar 

  35. Miller ED Jr, Samuels AI, Haber E, Barger AC: Inhibition of angiotensin conversion and prevention of renovascular hypertension. Am J Physiol 228: 448, 1975.

    PubMed  CAS  Google Scholar 

  36. Gavras H, Brunner HR, Vaughan ED Jr, Laragh JH: Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 180: 1369, 1973.

    Article  PubMed  CAS  Google Scholar 

  37. Johnson JA, Davis JO: Effects of a specific competitive antagonist and angiotensin II on arterial pressure and adrenal steroid secretion in dogs. Circ Res 32 (Suppl 1): 159, 1973.

    PubMed  CAS  Google Scholar 

  38. Sancho J, Re RM, Burton J, Barger AC, Haber E: The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 53: 400, 1976.

    PubMed  CAS  Google Scholar 

  39. Tagawa H, Gutmann FD, Haber E, Miller ED Jr, Samuels AI, Barger AC: Reversible renovascular hypertension and renal arterial pressure. Proc Soc Exp Biol Med 146: 975, 1974.

    PubMed  CAS  Google Scholar 

  40. Brunner HR, Kirshman JD, Sealey JE, Laragh JH: Hypertension of renal origin: evidence of two different mechanisms. Science 174: 1344, 1971.

    Article  PubMed  CAS  Google Scholar 

  41. Krieger EM, Saigado HC, Assan CJ, Greene LLJ, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system. Lancet 1: 269, 1971.

    Article  PubMed  CAS  Google Scholar 

  42. Skeggs LT, Kahn JR, Levine M, Dorer FE, Lentz KE: Chronic one-kidney hypertension in rabbits. III. Renopressin, a new hypertensive substance. Circulation Res 40: 143, 1977.

    PubMed  CAS  Google Scholar 

  43. Tobian L, Coffee K, McCrea P: Contrasting total exchangeable sodium levels in rats with two different types of Goldblatt hypertension. J Lab Clin Med 66: 1027, 1965.

    Google Scholar 

  44. Guyton AC, Coleman TG, Granger HJ: Circulation: overall regulation. Annu Rev Physiol 34: 13, 1972.

    Article  PubMed  CAS  Google Scholar 

  45. Rocchini AP, Barger AC: Renovascular hypertension in sodium-depleted dogs: role of renin in carotid sinus reflex. Am J Physiol (in press).

    Google Scholar 

  46. Deming QB, Leutscher JA: Bioassay of desoxycorticosterone-like material in urine. Proc Soc Exp Biol Med 73: 171, 1950.

    CAS  Google Scholar 

  47. Davis JO, Hartroft PM, Titus EO, Carpenter CCJ, Ayers CR, Speigel HE: The role of the renin-angiotensin system in the control of aldosterone secretion. J Clin Invest 41: 378, 1962.

    Article  PubMed  CAS  Google Scholar 

  48. Watkins L Jr, Burton JA, Haber E, Cant JR, Smith FW, Barger AC: The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57: 1606, 1976.

    Article  PubMed  CAS  Google Scholar 

  49. Schambelan M, Stockigt JR, Biglieri EG: Isolated hypoaldosteronism in adults: a renin-deficiency syndrome. N Eng J Med 287: 573, 1972.

    Article  CAS  Google Scholar 

  50. DeLeiva A, Christlieb AR, Melby JC et al.: Big renin and biosynthetic defect of aldosterone in diabetes mellitus. N Engl J Med 295: 639, 1976.

    Article  PubMed  CAS  Google Scholar 

  51. Gill JR, Frölich JC, Bowden RE et al.: Bartter’s syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med 61: 43, 1976.

    Article  PubMed  Google Scholar 

  52. McGiff JC: Bartter’s syndrome results from an imbalance of vasoactive hormones. Ann Intern Med 87: 369, 1977.

    PubMed  CAS  Google Scholar 

  53. Norby L, Lentz R, Flamenbaum W et al.: Prostaglandins and aspirin therapy in Bartter’s syndrome. Lancet 2: 604, 1976.

    Article  PubMed  CAS  Google Scholar 

  54. Katz FH, Bortz AI: Treatment of Bartter’s syndrome with naproxen. N Engl J Med 299: 100, 1978.

    Article  PubMed  CAS  Google Scholar 

  55. Brunner HR, Laragh JH, Baer L et al.: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441, 1972.

    Article  PubMed  CAS  Google Scholar 

  56. Kaplan NM: The prognostic implications of plasma renin in essential hypertension. JAMA 231: 167, 1975.

    Article  PubMed  CAS  Google Scholar 

  57. Thurston H, Swales JD: Low renin hypertension: a distinct entity. Lancet 2: 930, 1976.

    Article  PubMed  CAS  Google Scholar 

  58. When to measure renin? (Editorial). Lancet 1:783, 1975.

    Google Scholar 

  59. Kaplan NM: Renin profiles: the unfulfilled promises. JAMA 238: 611, 1977.

    Article  PubMed  CAS  Google Scholar 

  60. Drayer JI, Keim HJ, Wever MA et al.: Unexpected pressor responses to propranolol in essential hypertension: an interaction between renin, aldosterone, and sympathetic activity. Am J Med 60: 897, 1976.

    Article  PubMed  CAS  Google Scholar 

  61. Buhler FR, Burkart F, Lutold BE et al.: Antihypertensive beta-blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol 36: 653, 1975.

    Article  PubMed  CAS  Google Scholar 

  62. Buhler FR, Bertel P, Lutold BE: Simplified and age-stratified antihypertensive therapy based on beta blockers. Cardiovasc Med 3: 135, 1978.

    Google Scholar 

  63. Woods JW, Pittman AW, Pulliam CC et al.: Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. N Engl J Med 294: 1137, 1976.

    Article  PubMed  CAS  Google Scholar 

  64. Laragh JH: Symposium on hypertension: vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 55: 261, 1973.

    Article  PubMed  CAS  Google Scholar 

  65. Vaughan ED Jr, Laragh JH, Gavras I et al.: Symposium on high blood pressure: volume factor in low and renin essential hypertension: treatment with either spironolactone or chlorthalidone. Am J Cardiol 32: 523, 1973.

    Article  PubMed  Google Scholar 

  66. Drayer JI, Loppenborg PW, Festen J et al.: Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. Am J Cardiol 36: 716, 1975.

    Article  PubMed  CAS  Google Scholar 

  67. Simon N, Franklin SS, Bleifer KH et al.: Clinical characteristics of renovascular hypertension (cooperative study). JAMA 200: 1209, 1972.

    Article  Google Scholar 

  68. Re R, Novelline R, Escourrou M-T et al.: Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis. N Engl J Med 298: 582, 1978.

    Article  PubMed  CAS  Google Scholar 

  69. Marks LS, Maxwell MH: Renal Vein renin: value and limitations in the prediction of operative results. Urol Clin North Am 2: 311, 1975.

    PubMed  CAS  Google Scholar 

  70. Vaughan ED Jr, Buhler FR, Laragh JH et al.: Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am J Med 55: 402, 1973.

    Article  PubMed  Google Scholar 

  71. Brewster DC, Darling RC: Renal artery reconstruction. Surgical Rounds 1 (3): 18, 1978.

    Google Scholar 

  72. Gruntzig A, Vetter W, Meier B et al.: Treatment of renovascular hypertension with percutaneous transluminal dilation of the renal-artery stenosis. Lancet 1: 801, 1978.

    Article  PubMed  CAS  Google Scholar 

  73. Gruntzig A: Die perkutane transluminale Rekanalisation chronischer Arterienverschluesse mit einer neuen Dilatationstechnik. New York: Verlag Gerhad Witzstrock, 1977.

    Google Scholar 

  74. Tarazi RC, Ibrahim MM, Bravo EL et al: Hemodynamic characteristics of primary aldosteronism. N Engl J Med 289: 1330, 1973.

    Article  PubMed  CAS  Google Scholar 

  75. Brown JJ, Chinn RH, Davies DL et al.: Plasma electrolytes, renin, and aldosterone in the diagnosis of primary hyperaldosteronism: with a note on plasmacorticosterone concentration. Lancet 2: 55, 1968.

    Article  Google Scholar 

  76. Sambhi MP, Crane MG, Genest J: UCLA conference: essential hypertension: new concepts about mechanisms. Ann Intern Med 79: 411, 1973.

    Google Scholar 

  77. Merrill AJ, Morrison JL, Brannon ES: Concentration of renin in renal venous blood in patients with chronic heart failure. Am J Med 1: 468, 1948.

    Article  Google Scholar 

  78. Turini GA, Brunner HR, Ferguson RK, River JL, Gavras H: Congestive heart failure in man hemodynamics, renin, and angiotensin II blockade. Br Heart J 40: 1134, 1978.

    Article  PubMed  CAS  Google Scholar 

  79. Haddy FJ, Molner JI, Borden CW, Texter EC Jr: Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds. Circulation 25: 239, 1962.

    PubMed  CAS  Google Scholar 

  80. Johnson JA, Davis JO: Angiotensin II: Important role in the maintenance of arterial blood pressure. Science 179: 906, 1973.

    Article  PubMed  CAS  Google Scholar 

  81. Ganony WF, Biglieri EG, Murlow PJ: Mechanisms regulating adrenocorticoid secretion of aldosterone and glucocorticoids. Recent Prog Horm Res 22: 381, 1966.

    Google Scholar 

  82. Boyd GW, Adamson AR, James VHT, Peart WS: The role of the renin-angiotensin system in the control of aldosterone in man. Proc R Soc Med 62: 1253, 1969.

    PubMed  CAS  Google Scholar 

  83. Guiha NH, Coh JN, Mikulic E, Franciosa JA, Limas CJ: Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291: 587, 1974.

    Article  PubMed  CAS  Google Scholar 

  84. Franciosa JA, Mikluic E, Cohn JN, Jose E, Fabie A: Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation 50: 1020, 1974.

    PubMed  CAS  Google Scholar 

  85. Franciosa JA, Pierpont G, Cohn JN: Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med 86: 388, 1977.

    PubMed  CAS  Google Scholar 

  86. Franciosa JA, Cohn JN: Sustained hemodynamic effect during long term nitrates without tolerance in heart failure. Circulation 58 (Suppl II): 11–28, 1978.

    Google Scholar 

  87. Chatterjee K, Ports T, Rubin S, Massies B, Arnold S, Brundage B, Parmley W: Sustained beneficial hemodynamic effects during long-term hydralazine therapy in patients with chronic heart failure. Circulation 58 (Suppl II): 11–28, 1978.

    Google Scholar 

  88. Awan NA, Miller RR, Miller MP, Specht K, Vera Z, Mason DT: Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure: balanced systemic venous and arterial dilatation improving pulmonary congestion and cardiac output. Am J Med 65: 146, 1978.

    Article  PubMed  CAS  Google Scholar 

  89. Murtley VS, Waldron TL, Goldberg ME, Vollmer RR: Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits. Eur J Pharmacol 46: 207, 1977.

    Article  Google Scholar 

  90. Levine TB, Franciosa JA, Cohn JN: Acute and long-term response to oral-converting enzyme inhibitor, Captopril, in congestive heart failure. Circulation 62: 35, 1980.

    PubMed  CAS  Google Scholar 

  91. Dzau VJ, Colucci WS, Williams GH et al.: Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 302: 1373, 1980.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Edgar Haber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hypertension and Cardiovascular Rehabilitation Unit, Department of Pathophysiology, University of Leuven, K.U. Leuven, 3000, Leuven, Belgium

    A. Amery , R. Fagard , P. Lijnen  & J. Staessen , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Haber, E. (1982). Role of Renin in the Control of the Circulation in Hypertensive Disease and in Heart Failure. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7476-0_19

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7478-4

  • Online ISBN: 978-94-009-7476-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation